M.Tuberculosis and HIV-Prolific Killers in Developing Countries are Syndemic Pathogens by M V Hosur

Mycobacterium tuberculosis (Mtb) infection accounts for the highest number of human deaths in low- and middle-income

Tuberculosis in Elephants and its Implications during COVID-19 by Rudrodip Majumdar

Tuberculosis in captive Asian elephants has been a subject of interest among the experts and practitioners for the pa

Ground Breaking Advancements in TB Treatment Regimen by Shingar and Pawan Sharma

A six-month-long duration of TB treatment under the DOTS programme is fraught with issues like non-compliance by pati

Let's Make the Worldwide Fight Against COVID Transformative for Other Global Threats like TB : TBINFO EDITORIAL

Bacteriophages as Therapeutics for Managing Drug-Resistant Tuberculosis? by Urmi Bajpai

The world health organization has predicted high mortality rates due to infection by drug-resistant pathogens and has

It's Time to ACT!!! by Anshu Bhardwaj

The Pandemic has caused severe damage to the progress made in addressing Tuberculosis.

Tuberculosis: A Brief Overview and Recent Advancements in Clinical Treatment by Rudrodip Majumdar

Tuberculosis, which is also popularly called as TB, is one of the most ancient diseases that has stayed and co-evolve